Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Adriana C VidalLauren E HowardAmanda M De HoedtChristopher J KaneMartha K TerrisWilliam J AronsonMatthew R CooperbergChristopher L AmlingStephen J FreedlandPublished in: BJU international (2018)
Amongst patients with non-mCRPC obesity was associated with better overall survival. Although this result mirrors evidence from men with mCRPC, obesity was not associated with prostate cancer outcomes. Larger studies are needed to confirm these findings.
Keyphrases
- obese patients
- weight loss
- bariatric surgery
- prostate cancer
- insulin resistance
- metabolic syndrome
- roux en y gastric bypass
- type diabetes
- gastric bypass
- high fat diet induced
- weight gain
- papillary thyroid
- adverse drug
- radical prostatectomy
- healthcare
- squamous cell
- adipose tissue
- emergency department
- squamous cell carcinoma
- free survival
- skeletal muscle
- physical activity
- childhood cancer
- drug induced